| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d46f8170b2550db9a396cfe3400401e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35c628250978a38f54ea6a1c95d618de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45d570de974d6565b5a684cf7ddb21e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6d0c613d59fac9d6062a585dc0826eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate |
2010-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e991d6334d2b4ccc30931a08a4b7070
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b03e9f36c37f908cde8cfc1f8511038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67f3da794061b679552e0896aa2e12ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2cc4a53c588de0bab20c7c28c9c8f4f |
| publicationDate |
2015-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9221909-B2 |
| titleOfInvention |
Antibodies against human EPO receptor |
| abstract |
An antibody binding to human EPO-R, characterized in specifically binding pY461, pY430 or p465 is useful for the determination of activated EPO receptor. |
| priorityDate |
2009-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |